Scott L. Silliman
|
|
Location:
University of Florida
Education:
| Albany Medical Center | Internship, 1989 | ||
| Albany Medical College | M.D., 1988 | ||
| University of Chicago | B.A. in Biology, 1984 |
Awards and Recognition:
Innovative Program Award, “Strike-Out Stroke Screening Program”, Albert Einstein Society 1995
Preceptorship Award, American College of Physicians, 1996
Research Advisor to Denise Sigmon, Pharmacy Resident, 1997
This project received the Florida Association of Hospital Pharmacists’ ROCHE Award for the most outstanding clinical research project by a pharmacy resident in Florida.
Recipient of the “Jacksonville Excellence in Healthcare” Award, 1998
Sponsored by AvMed Health Plan, the Jacksonville Business Journal, KPMG Peat Marwick LLP and Pfizer Inc.
University of Florida, “Excellence in Medical Student Education” Award, 1999
University of Florida, Dean Louis Russo Award for Outstanding, 2002 Professionalism in Medicine
Exemplary Teacher; University of Florida College of Medicine, 2002, 2003, 2006, 2007,
2008
National M.S. Society North Florida Chapter: MS Ambassador of the Year, 2005
Research Interests:
Cerebrovascular disease and multiple sclerosis
Recent Publications:
Crary MA, Mann GD, Miller LA, Antonios N, Silliman SL. Dysphagia and nutritional status
following ischemic stroke. Journal of Stroke and Cerebrovascular Disease 2006; 15:164-171.
Meschia JF, Case LD, Worrall BB, Brown RD, Brott TG, Frankel M, Silliman S, Rich SS for the
Ischemic Stroke Genetics Study Group. Family history of stroke and severity of neurologic deficit after stroke. Neurology 2006;67:1396-1402.
Meschia JF, Barrett KM, Chukwudelunza F, Brown WM, Case D, Kissela BM, Brown RD, Brott TG, Olsen TS, Rich S, Silliman S, Worrall BB, for the Siblings with Ischemic Stroke Study (SWISS) Investigators. Inter-observer agreement in the Trail of Org 10172 in Acute Stroke Treatment: classification of stroke based on retrospective medical record review. J Stroke and Cerebrovascular Diseases 2006;15:266-272.
Matarin M, Brown WM, Scholz S, Simon-Sanchez J, Fung HC, Hernandez D, Gibbs JR, De Vrieze FW, Crews C, Britton A, Langefeld CD, Brott TG, Brown RD Jr, Worrall BB, Frankel M, Silliman S, Case LD, Singleton A, Hardy JA, Rich SS, Meschia JF. A genome-wide genotyping study in patients with ischaemic stroke: initial anaylsis and data release. Lancet Neurol. 2007;6:414-20.
Barrett KM, Brott TG, Brown RD Jr., Frankel MR, Worrall BB, Silliman SL, Case LD, Rich SS, Meschia JF for the Ischemic Stroke Genetics Study Group. Sex differences in stroke severity, symptoms, and deficits after first-ever ischemic stroke. J Stroke Cerebrovasc Dis 2007;16:34-39.
Leslie-Mazwi TM, Brott TG, Brown RD, Worrall BB, Silliman SL, Case LD, Frankel MR, Rich SS, Meschia JF. Sex differences in stroke evaluations in the Ischemic Stroke Genetics Study. Stroke and Cerebrovascular Diseases 2007;16:187-193.
Guzman LA, Costa MA, Angiolillo DJ, Zenni M, Wludyca P, Silliman S, Bass TA. A Systemic Review of Outcomes in Patients with Staged Carotid Artery Stenting and Coronary Artery Bypass Graft Surgery. Stroke 2008; 39:361-365.
Matarin M, Simon-Sanchez J, Fung HC, Scholz S, Gibbs JR, Hernandez DG, Crews C, Britton A, Wavrant De Vrieze F, Brott TG, Brown RD Jr., Worrall BB, Silliman S, , Case LD, Hardy JA, Rich SS, Meschia JF, Singleton A. Hernandez D, Crews C. Structural Genomic Variation in Ischemic Stroke. Neurogenetics 2008;9:101-108.
Chen DT, Case D, Brott TG, Brown RD Jr. Silliman, SL, Meschia JF, Worrall BB for the Ischemic Stroke Genetic Study Investigators. Stroke 2008;39:831-837.
Meschia J, Kissela B, Brott T, Brown Jr. R, Silliman S, Brown M, Rich S. Proband Race/Ethnicity Affects Pedigree Completion Rate in a Genetic Study of Ischemic Stroke. Journal of Stroke and Cerebrovascular Diseases 2008 (accepted).
Antonios N, Angiolillo DJ, Silliman S. Hypertriglyceridemia and Ischemic Stroke. European Neurology 2008 (accepted).
Bhatt DL, Fox KAA, Hacke W, et al. for the Charisma Investigators. Clopidigrel and aspirin versus aspirin more for the prevention of atherothrombotic events. N Eng J Med 2006; 354: 1706-1717. (Site P.I)
Diener HC, Sacco R, Yusuf S. Rationale, Design and Baseline Data of a Randomized, Double-Blind, Controlled Trial Comparing Two Antithrombotic Regimens (a Fixed-Dose Combination of Extended-Release Dipyridamole plus ASA with Clopidogrel) and Telmisartan versus Placebo in Patients with Strokes: The Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS). Cerebrovascular Diseases. 2007.23:368-380. (Site P.I.)
Cohen JA, Calabresi PA, Chakraborty S, et al. for the ACT Investigators. Avonex combination Trial in relapsing-remitting MS: rationale, design, and baseline data. Multiple Sclerosis 2007;00:1-13.
Mayer SA, Brun NC, Begtrup K., et al. for the FAST Trial Investigators. Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage. N Eng J Med 2008; 358:2127-2137. (site P.I.)
Contact Information:
UFHSC/Jacksonville
Department of Neurology
580 West 8th Street, 9th Floor Tower 1
Jacksonville, FL 32209-6511
Phone: (904) 244-9945